290650.KQ KOE
L&C Bio Co., Ltd
1W: +13.8%
1M: +3.4%
3M: -40.8%
YTD: -40.5%
1Y: +58.2%
3Y: +52.8%
5Y: +62.0%
₩53,700.00 ($39.74)
-2600.00 (-4.62%)
Weekly Expected Move ±10.6%
₩42317
₩48009
₩53700
₩59391
₩65083
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩1.32T ($978.1M)
52W Range42150-125000
Volume295,149
Avg Volume312,270
Beta1.36
Dividend₩50.00
Analyst Ratings
No analyst coverage
Company Info
CEOChul Lee Whan
Employees155
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-11-01
Websitelncbio.co.kr
Suntechcity
Seongnam-si, GY 13229
KR
Seongnam-si, GY 13229
KR
82 3 1731 7050
About L&C Bio Co., Ltd
Specializing in regenerative tissue medicine, L&C BIO Co., Ltd. operates as a dedicated research and development enterprise. The company's diverse product range encompasses human tissue products, various medical devices, and a selection of cosmetic solutions. Established in 2011, this firm is headquartered in Seongnam, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found